米非司酮治疗宫内残留疗效与B超及病理检查对照研究.docVIP

米非司酮治疗宫内残留疗效与B超及病理检查对照研究 　　[摘要] 目的:研究米非司酮治疗宫内残留的疗效与其B超及病理检查的关系。方法:160例宫内残留者均采用米非司酮治疗,按治疗前B超检查宫内残留物大小分为30 mm组38例三组,记录三组排出物或刮出物大小及病理组织的结果,观察其治疗效果与B超及排出物病理检查的关系。结果:三组疗效分别为97.06%、85.19%、57.89%,两两比较有显著性差异(P0.05)。病理结果:胚胎组织占多数为85%,余为陈旧性血块伴炎性细胞占15%,此两种类型疗效分别为80.88%、100.00%,两者之间比较有显著性差异(P30 mm者,要密切观察临床症状,必要时及时行刮宫术,治疗的同时要抗感染治疗。 　　[关键词] 米非司酮;宫内残留;B超;病理;对照研究 　　[中图分类号] R445.1[文献标识码]A [文章编号]1673-7210(2010)06(b)-026-02 　　 　　Control study on the residual effect of mifepristone treatment of intrauterine and the B-ultrasonography and pathological examination 　　LI Qiuyue, TONG Ganyi, HUANG Huihong 　　(The Peoples Hospital of Huiyang District in Huizhou City, Huizhou 516211, China) 　　[Abstract] Objective: To study the relationship between the efficacy of mifepristone on the treatment of intrauterine residue and B-ultrasonography or pathological detection. Methods: 160 cases of patients with residual caught intrauterine were treated with mifepristone, were divided into three groups by B-ultrasonography before treatment of intrauterine residue size: 68 cases 30 mm, the discharges or scrapings size and pathology results of three groups were recorded, and the relationship between the efficacy of mifepristone and B-ultrasonography or pathological detection were observed. Results: The efficacy of the three groups were 97.06%, 85.19%, 57.89%, there were significant differences(P0.05). Pathology results: embryonic tissue, the majority was 85%, more than the old blood clots associated with inflammatory cells (15%), the efficacy of the two groups were 80.88%, 100.00%, there was a significant difference between the two groups (P30 mm and the clinical symptoms should be closely observed, if necessary, curettage surgery and anti-infection treatment at the same time. 　　[Key words] Mifepristone; Intrauterine residue; B-ultrasonography; Pathology; Control study 　　 　　宫内组织残留是产后、引产后或流产后较为常见的并发症之一,米非司???是一种抗孕激素药,具有抗排卵、抗着床、扩张和软化宫颈作用,广泛应用于流产及宫内残留。2006年1月～2009年12月,笔者观察了米非司酮治疗宫内残留160例患者的疗效与B超及残留物病理